UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

Hepatology (Baltimore, Md.), 2010-09, Vol.52 (3), p.886-893

2010

Volltextzugriff (PDF)

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.422-430

2010

Volltextzugriff (PDF)

Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

Hepatology (Baltimore, Md.), 2008-09, Vol.48 (3), p.750-758

2008

Volltextzugriff (PDF)

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Hepatology (Baltimore, Md.), 2011-01, Vol.53 (1), p.62-72

2011

Volltextzugriff (PDF)

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

The New England journal of medicine, 2006-03, Vol.354 (10), p.1001-1010

2006

Volltextzugriff (PDF)

Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study

American journal of epidemiology, 2007-07, Vol.166 (2), p.196-203

2007

Volltextzugriff (PDF)

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Journal of hepatology, 2009-02, Vol.50 (2), p.289-295

2009

Volltextzugriff (PDF)

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

Hepatology (Baltimore, Md.), 2001-06, Vol.33 (6), p.1527-1532

2001

Volltextzugriff (PDF)

Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents

Journal of medical virology, 2011-04, Vol.83 (4), p.602-607

2011

Volltextzugriff (PDF)

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B

Journal of gastroenterology and hepatology, 2004-11, Vol.19 (11), p.1276-1282

2004

Volltextzugriff (PDF)

A One-Year Trial of Lamivudine for Chronic Hepatitis B

The New England journal of medicine, 1998-07, Vol.339 (2), p.61-68

1998

Volltextzugriff (PDF)

Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy‐proven histological damage

Hepatology (Baltimore, Md.), 2010-04, Vol.51 (4), p.1185-1189

2010

Volltextzugriff (PDF)

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

The New England journal of medicine, 2006-03, Vol.354 (10), p.1011-1020

2006

Volltextzugriff (PDF)

Strong Association of Hepatitis C Virus (HCV) Infection and Thrombocytopenia: Implications from a Survey of a Community with Hyperendemic HCV Infection

Clinical infectious diseases, 2004-09, Vol.39 (6), p.790-796

2004

Volltextzugriff (PDF)

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection

Hepatology (Baltimore, Md.), 2001, Vol.33 (1), p.277-286

2001

Volltextzugriff (PDF)

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

The New England journal of medicine, 2005-06, Vol.352 (26), p.2673-2681

2005

Volltextzugriff (PDF)

Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

Journal of gastroenterology and hepatology, 2007-09, Vol.22 (9), p.1494-1499

2007

Volltextzugriff (PDF)

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 2000-07, Vol.119 (1), p.172-180

2000

Volltextzugriff (PDF)

Therapy with interferon-α and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells

Journal of medical virology, 2008-06, Vol.80 (6), p.989-996

2008

Volltextzugriff (PDF)

Plastic Microchip Electrophoresis for Analysis of PCR Products of Hepatitis C Virus

Clinical chemistry (Baltimore, Md.), 1999-11, Vol.45 (11), p.1938-1943

1999

Volltextzugriff (PDF)

Association of serum IgG N-glycome and transforming growth factor-β1 with hepatitis B virus e antigen seroconversion during entecavir therapy

Antiviral research, 2014-11, Vol.111, p.121-128

2014

Volltextzugriff (PDF)

Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B

Journal of medical virology, 2007-06, Vol.79 (6), p.663-669

2007

Volltextzugriff (PDF)

Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection

Journal of gastroenterology and hepatology, 2000-05, Vol.15 (5), p.519-528

2000

Volltextzugriff (PDF)

Detection of HCV RNA in saliva, urine, seminal fluid, and ascites

Journal of medical virology, 1992-07, Vol.37 (3), p.197-202

1992

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

ThemaViral Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(44)
Tagungsberichte
(1)

Sprache

Englisch
(45)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(44)
Human Viral Diseases
(44)
Infectious Diseases
(44)
Medical Sciences
(44)
Viral Hepatitis
(41)
Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Humans
(39)
Male
(32)
Female
(31)
Adult
(27)
Middle Aged
(24)
Gastroenterology & Hepatology
(18)
Aged
(15)
Hepatitis B Virus
(14)
Hepatitis C Virus
(13)
Antiviral Agents - Therapeutic Use
(12)
Hepatitis B, Chronic - Drug Therapy
(12)
Virology
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B

A One-Year Trial of Lamivudine for Chronic Hepatitis B

Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy‐proven histological damage

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

Strong Association of Hepatitis C Virus (HCV) Infection and Thrombocytopenia: Implications from a Survey of a Community with Hyperendemic HCV Infection

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B

Therapy with interferon-α and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells

Plastic Microchip Electrophoresis for Analysis of PCR Products of Hepatitis C Virus

Association of serum IgG N-glycome and transforming growth factor-β1 with hepatitis B virus e antigen seroconversion during entecavir therapy

Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B

Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection

Detection of HCV RNA in saliva, urine, seminal fluid, and ascites

Aktive Filter

Suchergebnisse filtern